| Literature DB >> 27137091 |
Jin-Wu Nam1,2, Seo-Won Choi1, Bo-Hyun You1.
Abstract
Since the RNA world hypothesis was proposed, a large number of regulatory noncoding RNAs (ncRNAs) have been identified in many species, ranging from microorganisms to mammals. During the characterization of these newly discovered RNAs, RNAs having both coding and noncoding functions were discovered, and these were considered bifunctional RNAs. The recent use of computational and high-throughput experimental approaches has revealed increasing evidence of various sources of bifunctional RNAs, such as protein-coding mRNAs with a noncoding isoform and long ncRNAs bearing a small open reading frame. Therefore, the genomic diversity of Janus-faced RNA molecules that have dual characteristics of coding and noncoding indicates that the functional roles of RNAs have to be revisited in cells on a genome-wide scale. Such studies would allow us to further understand the complex gene-regulatory network in cells. In this review, we discuss three major genomic sources of bifunctional RNAs and present a handful of examples of bifunctional RNA along with their functional roles.Entities:
Keywords: bifunctional RNA; lncRNA; sORF
Mesh:
Substances:
Year: 2016 PMID: 27137091 PMCID: PMC4870183 DOI: 10.14348/molcells.2016.0039
Source DB: PubMed Journal: Mol Cells ISSN: 1016-8478 Impact factor: 5.034
Fig. 1.Four relevant scenarios of the generation of RNAs or genes with coding and noncoding functions. (A) lncRNAs with sORF. (B) Protein-coding mRNAs having non-coding functions. (C) Coding and noncoding isoforms of protein-coding genes by alternative splicing. (D) Allele-specific expression of coding and noncoding isoforms.
lncRNAs with ribosome association
| Gene_ID | Species | Transcript (nt) | Putative ORF (nt) | TE | RPM | RRS |
|---|---|---|---|---|---|---|
| RP5-875O13.1 | Human | 1548 | 78 | 3.26 | 122.76 | 0.15 |
| CGAT1 | Human | 2131 | 210 | 0.40 | 45.71 | 42.01 |
| SNHG8 | Human | 672 | 159 | 1.62 | 33.40 | 52.62 |
| MALAT1 | Human | 8708 | 213 | 0.01 | 26.99 | 1184.00 |
| CTD-2651B20.6 | Human | 308 | 72 | 3.99 | 21.92 | 0.12 |
| GAS5 | Human | 1698 | 502 | 0.10 | 21.82 | 170.13 |
| AC074183.4 | Human | 782 | 186 | 5.44 | 20.37 | 78.00 |
| DANCR | Human | 878 | 180 | 0.23 | 14.47 | 116.37 |
| RP11-21N3.1 | Human | 918 | 300 | 1.05 | 12.51 | 488.00 |
| RP11-220I1.1 | Human | 4375 | 192 | 0.18 | 11.58 | 371.20 |
| RP11-354P17.9 | Human | 745 | 246 | 0.93 | 11.38 | 69.54 |
| RPPH1 | Human | 638 | 108 | 0.22 | 10.34 | 8.00 |
| RP23-381B19.2 | Mouse | 1428 | 279 | 0.16 | 25.85 | 70.33 |
| Malat1 | Mouse | 6983 | 195 | 0.01 | 17.40 | 1998.00 |
| RP23-73N16.7 | Mouse | 475 | 162 | 0.81 | 12.82 | 0.42 |
| Gas5 | Mouse | 2556 | 177 | 0.05 | 8.44 | 80.66 |
Translation Efficiency (TE)
Read per million mapped reads (RPM)
Ribosome Release Score (RRS)
Fig. 2.Ribosome-association signals on lncRNAs. (A) Strong RPF signals in a sORF of MALAT1 in HeLa cells and Malat1 in mouse neutrophils are shown. Yellow and green bars are EpsG protein and EpsG superfamily domains, respectively, detected from the NCBI Conserved Domain Database. (B) RPF signals in the lncRNA RP11-21N3_1 in HeLa cells.
List of bifunctional RNAs
| Bifunctional RNA | Species | RNA length | Peptide length | Coding function | Intrinsic function of RNA | RNA function category | References |
|---|---|---|---|---|---|---|---|
| 514 nt | 26 aa | Delta-hemolysin that targets host cell membranes, causing lysis | Regulation of stability and translation of virulence factors by base pairing | Translation | |||
| 227 nt | 43 aa | SgrT, relieving glucose stress through a base pairing-independent mechanism | Negative regulation of the stability and translation of the major gulcose transporters ptsG and manXYZ via base pairing | Translation | |||
| 117 nt | 39 aa | SR1P, stabilizing gapA operon RNA by binding to gapA protein but not RNA | Repression of transcription activator | Transcription | |||
| ∼700 nt | I: 13 aa, II: 27 aa | Two ORFs, cell divisions at high frequency. Two peptides binds to sucrose synthase | MtRBP1 interacting with a secondary structure of interORF region, which is involved in translation regulation | Translation | |||
| 2703 nt | 455 aa | VegT codes for a T-box TF that patterns the mesendoderm | VegT mRNA and ncRNA, Xlsirts play structural roles in the organization of the cytoskeleton at the vegetal cortex | Scaffolding | |||
| 2869 nt | 606 aa | Involved in late oogenesis function | Oskar 3′UTR, scaffolding RBPs, regulating early oogenesis function | Scaffolding | |||
| 1480 nt | 392 aa | Nodal signaling in mesendoderm induction and patterning, and specification of the neural tube | Sqt 3′UTR, scaffolding RBPs, initiation of dorsal axis specification | Scaffolding | |||
| - | - | Oncogenic and tumor suppressor function | Cis-trascriptional regulation by binding to PRC2 and EZH2, polycomb repressive complex | Transcription | |||
| 3243 nt | 639 aa | Delayed onset of mild myotonic dystrophy symptoms | DMPK 3′UTR, CUG repeat forms hairpin structure that sequesters developmentally regulated splicing factors like MBNL, leading to severe myotonic dystrophy symptoms | Scaffolding | |||
| 2591 nt | 393 aa | Transcription factor in response to DNA-damage, hypoxia, nutrient deprivation, and telomere damage, which can lead to cancer. Initiating a program of cell cycle arrest and apoptosis | Enhance p53 translation and stabilization by interacting with Mdm2 | Translation | |||
| 431 nt | 126 aa | Replication-dependent histone gene | Nucleation of nuclear bodies (histone locus bodies, nuclear speckles, paraspeckles, and nuclear stress bodies) | Scaffolding | |||
| 5312 nt | 152 aa | Involved in transcriptional regulation of viral genome expression | HIC 3′UTR hairpin structure, binds to and activates P-TEFb by displacing 7SK RNA from inhibitory complex | Translation | |||
| >345 nt | 115 aa | p12, ? | BCMA translation repression | Translation | |||
| 4814 nt | 197 aa | Control of homeostasis | Inhibits translation by interacting with the RNA binding domain of PKR | Translation | |||
| SMD targets | varying | varying | varying | Stability control of interacting SMD targets and lncRNA via Alu repeats | Post-transcription | ||
| SRA | 2015 nt | 236 or 208 aa | RNA binding and related to breast cancer | Nuclear receptor coactivator | Coactivator |
Fig. 3.An example of coding and noncoding isoforms from the human SRA gene with 5 exons, which is conserved in the mouse. The human SRA gene has 2 alternative start codons, whereas mouse SRA has 1 start codon and 2 stop codons. The gene produces both coding and noncoding isoforms, with the first intron retained in both human and mouse.